Hexo

Cannabis firm's shares hit a 2021 peak of US$10 on the NYSE in mid-February and have since fallen by 74 per cent.
Company has been issuing new shares at a steady clip as it seeks to finance its ambitious expansion plans.
Cannabis producer is transferring its U.S. listing from the New York Stock Exchange in a move that's expected to take effect next week.
Company that’s aiming to become Canada’s first qualified custodian for cryptocurrency assets sees "huge opportunity" in emerging industry.
Ottawa-based firm's net revenue totalled $22.7 million, up from $22.1 million in the same quarter last year.
Ottawa firm was one of three major Canadian pot producers hit with lawsuits last year alleging they exaggerated or overestimated sales figures and market potential.
Smiths Falls-based cannabis firm reported a net loss of nearly $700 million in its fourth quarter, down from a loss of $1.3 billion in the same quarter last year.
Ottawa-based cannabis firm said Friday it will pay $400 million in cash and $525 million in shares for Toronto-based Redecan as it continues to hunt for more market share.
CEO of Ottawa-based firm says arrangement would leverage Hexo's technology to help multi-state operators boost their product quality and margins while lowering costs.
Hexo CEO Sebastien St-Louis said 48North’s strength in topical CBD- and THC-infused creams and ointments was a major selling point as Ottawa firm looks to expand its product lines.